期刊文献+

Optimal pig donor selection in islet xenotransplantation: current status and future perspectives 被引量:1

异种胰岛移植中供体猪的筛选:现状与进展(英文)
原文传递
导出
摘要 Islet transplantation is an attractive treatment of type 1 diabetes mellitus. Xenotransplantation, using the pig as a donor, offers the possibility of an unlimited supply of islet grafts. Published studies demonstrated that pig islets could function in diabetic primates for a long time (〉6 months). However, pig-islet xenotransplantation must overcome the selection of an optimal pig donor to obtain an adequate supply of islets with high-quality, to reduce xeno- antigenicity of islet and prolong xenograft survival, and to translate experimental findings into clinical application. This review discusses the suitable pig donor for islet xenotransplantation in terms of pig age, strain, structure/function of islet, and genetically modified pig. 猪胰岛细胞异种移植是一种极具潜力治疗糖尿病的方法。其临床应用主要面临两大挑战:高质量的活性胰岛短缺与异种免疫排斥反应。合适的猪供体筛选(年龄、性别、品系、基因表型)是获取充足的高性能胰岛移植物的重要前提,并可有效地减轻胰岛异种抗原性及体内异种排斥反应,进而延长移植物的功能存活时间。在文中,我们总结了异种移植中猪胰岛的相关研究进展,为供体猪的筛选提供了依据;同时表明了无特殊病原体的成年转基因猪可能是目前最佳的异种胰岛供体,有望在未来的临床研究中大规模应用。
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2014年第8期681-691,共11页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 supported by the National Natural Science Foundation of China(No.30700772)
关键词 ISLET PIG XENOTRANSPLANTATION DONOR 胰岛 异种移植 供体
作者简介 Corresponding author E-mail: zht0915@ 163.com;Corresponding author bobwang75@yeah.net
  • 相关文献

参考文献2

二级参考文献24

  • 1Cooper DKC, Human PA, Lexer G, Rose AG, Rees J, Keraan M, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the ba- boon. J Heart Transplant 1988; 7: 238-46.
  • 2Rose AG, Cooper DKC, Human PA, Reichenspurner H, Reichart B. Histopathology of hyperacute rejection of the heart-experimental and clinical observations in allo- grafts andxenografts. J Heart Lung Transplant 1991; 10: 223-34.
  • 3Lambrigts D, Sachs DH, Cooper DKC. Discordant or- gan xenotransplantation in primates - world experience and current status. Transplantation 1998; 66: 547-61.
  • 4Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med. 1995; 1: 964-9.
  • 5Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, et al. Targeted disruption of the alphal, 3-galactos- yltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-5.
  • 6Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, et al. Production of cq,3-galactosyltransferase- deficient pigs. Science. 2003; 299: 411-4.
  • 7Ekser B, Kumar G, Veroux M, Cooper DKC. Therapeu- tic issues in the treatment of vascularized xenotrans- plants using Gal-knockout donors in nonhuman primates. Curr Opin Organ Transplant. 2011; 16: 222-30.
  • 8Houser SL, Kuwaki K, Knosalla C, Dor FJ, Gollackner B, Cheng J, et al, Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11: 416-25.
  • 9Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotrans- plantation-the next medical revolution? Lancet 2012; 379: 672-83.
  • 10Cooper DKC, Ekser B, Burlak C, Ezzelarab M, Hara H, Paris L, et al. Clinical lung xenotransplantation- what genetic modifications to the pig may be necessary? Xenotransplantation. 2012; 19: 144-58.

共引文献6

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部